Clinical Trial Update: Avelumab in Refractory Testicular Germ Cell Cancer. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of avelumab in refractory testicular germ cell cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Germ Cell Tumors
• Testicular Neoplasms

Drugs mentioned

• Avelumab (avelumab)

Snippet

Sponsor: National Cancer Institute, Slovakia | Conditions: Testicular Neoplasms, Neoplasms, Germ Cell and Embryonal | Phase 2 | Status: COMPLETED